203 related articles for article (PubMed ID: 27456536)
1. Oxidative stress induces transient O-GlcNAc elevation and tau dephosphorylation in SH-SY5Y cells.
Kátai E; Pál J; Poór VS; Purewal R; Miseta A; Nagy T
J Cell Mol Med; 2016 Dec; 20(12):2269-2277. PubMed ID: 27456536
[TBL] [Abstract][Full Text] [Related]
2. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
[TBL] [Abstract][Full Text] [Related]
3. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
[TBL] [Abstract][Full Text] [Related]
4. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.
Lefebvre T; Ferreira S; Dupont-Wallois L; Bussière T; Dupire MJ; Delacourte A; Michalski JC; Caillet-Boudin ML
Biochim Biophys Acta; 2003 Jan; 1619(2):167-76. PubMed ID: 12527113
[TBL] [Abstract][Full Text] [Related]
5. A genetic model to study
St Amand MM; Bond MR; Riedy J; Comly M; Shiloach J; Hanover JA
J Biol Chem; 2018 Aug; 293(35):13673-13681. PubMed ID: 29954943
[No Abstract] [Full Text] [Related]
6. O-GlcNAcylation and neurodegeneration.
Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
[TBL] [Abstract][Full Text] [Related]
7. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
Yuzwa SA; Shan X; Macauley MS; Clark T; Skorobogatko Y; Vosseller K; Vocadlo DJ
Nat Chem Biol; 2012 Feb; 8(4):393-9. PubMed ID: 22366723
[TBL] [Abstract][Full Text] [Related]
8. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
Gong CX; Liu F; Iqbal K
Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
[TBL] [Abstract][Full Text] [Related]
10. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
Ahmad W; Shabbiri K; Ahmad I
Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
[TBL] [Abstract][Full Text] [Related]
11. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
[TBL] [Abstract][Full Text] [Related]
12. Does O-GlcNAc play a role in neurodegenerative diseases?
Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
[TBL] [Abstract][Full Text] [Related]
13. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.
Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD
Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
15. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
17. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
Vosseller K; Wells L; Hart GW
Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
[TBL] [Abstract][Full Text] [Related]
18. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
19. The Role of Stress-Induced O-GlcNAc Protein Modification in the Regulation of Membrane Transport.
Fisi V; Miseta A; Nagy T
Oxid Med Cell Longev; 2017; 2017():1308692. PubMed ID: 29456783
[TBL] [Abstract][Full Text] [Related]
20. Intracellular protein glycosylation modulates insulin mediated lifespan in C.elegans.
Rahman MM; Stuchlick O; El-Karim EG; Stuart R; Kipreos ET; Wells L
Aging (Albany NY); 2010 Oct; 2(10):678-90. PubMed ID: 20952811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
